DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy
Stempeucel is used in the treatment of Buerger’s disease
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?
Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma…
Indian scientists develop breakthrough dengue drug
The project was jointly undertaken by DBT, ICGEB and Ranbaxy Research Laboratory and employed Ayurveda in devising the drug In a…
Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’
The product will be available under the brand name ‘Ledisof’ in India
EU’s ban of 700 pharma products will impact Indian pharma export by $1 bn
Indian govt defers FTA talks with EU
New drug capsule shells offer new choice: veg or non-veg
Expert panel to meet tomorrow to decide on gelatin versus cellulose Veg or non-veg? Not too far in the future, the person asking…